Abstract
R51163, a newly synthesized purine alkyl piperidine that produces reliable sedation in cattle, was tested in five adult bull moose (Alces alces). Compared with controls, all animals dosed with 0.4 mg/kg BW ate significantly (P less than 0.05) less dry matter for at least 1 wk after treatment. Median estimates of resting metabolism, measured the day of injection, did not differ between treatment and control groups, although the coefficient of variation was almost two times larger for drugged (15%) versus control (8%) individuals. Dose response was allometric, with larger animals exhibiting longer effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.